The Food and Drug Administration is ramping up technology adoption, and prioritizing AI and data strategies to ensure safety of new interventions and medical devices, improve workflows and ultimately deliver on its public health mission. Arunan Skandarajah, an FDA Presidential Innovation Fellow who believes in the power of equitable digital tools, discusses how he is innovating FDA’s regulatory processes to drive greater efficiencies.
HealthCast
Season 2
Episode 30
36m listen
How AI, Data Are Boosting FDA’s Regulatory Processes
A Presidential Innovation Fellow is helping the agency improve workflows and ultimately ensure safety of the drugs and treatments it regulates.
-
Arunan Skandarajah Presidential Innovation Fellow FDA
Related Content
-
Trump Nominees Enter Senate Confirmation Hearings This Week
Donald Trump’s cabinet picks will begin Senate hearings this week. This includes VA's Doug Collins and others shaping future IT priorities.
6m read -
AI Building Blocks
Join us for a half day workshop where you’ll walk away with these key takeaways on mastering key AI concepts, explore use cases, and more.
-
AI in Action
Join us for a half day workshop with these key takeaways: master key AI concepts, explore everyday use cases, and asking the right questions.
-
Data Drives the Future of Health Care
Federal data initiatives across the Department of Health and Human Services aim to improve health outcomes by enhancing data sharing, privacy and security across the health care ecosystem.
30m watch
